Stryker Non Current Liabilities Total from 2010 to 2024
SYK Stock | USD 327.99 0.46 0.14% |
Non Current Liabilities Total | First Reported 1985-12-31 | Previous Quarter 13.4 B | Current Value 13.3 B | Quarterly Volatility 5 B |
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 373.8 M or Total Revenue of 21.5 B, as well as many exotic indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0053 or PTB Ratio of 6.37. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
Stryker | Non Current Liabilities Total |
Latest Stryker's Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of Stryker over the last few years. It is Stryker's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
Timeline |
Stryker Non Current Liabilities Total Regression Statistics
Arithmetic Mean | 8,884,226,667 | |
Geometric Mean | 4,990,497,696 | |
Coefficient Of Variation | 59.63 | |
Mean Deviation | 4,575,878,222 | |
Median | 8,900,000,000 | |
Standard Deviation | 5,297,769,805 | |
Sample Variance | 28066364.9T | |
Range | 16.2B | |
R-Value | 0.95 | |
Mean Square Error | 3148370.5T | |
R-Squared | 0.90 | |
Slope | 1,121,224,286 | |
Total Sum of Squares | 392929108.7T |
Stryker Non Current Liabilities Total History
About Stryker Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Stryker income statement, its balance sheet, and the statement of cash flows. Stryker investors use historical funamental indicators, such as Stryker's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although Stryker investors may use each financial statement separately, they are all related. The changes in Stryker's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Stryker's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Stryker Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Stryker. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Non Current Liabilities Total | 13.4 B | 14.1 B |
Currently Active Assets on Macroaxis
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:Check out the analysis of Stryker Correlation against competitors. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Stryker Stock analysis
When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
CEOs Directory Screen CEOs from public companies around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.331 | Dividend Share 3.1 | Earnings Share 8.77 | Revenue Per Share 55.173 | Quarterly Revenue Growth 0.097 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.